$IEX · IDEX CORP /DE/
IDEX Corporation reported Q3 FY2026 results with record net sales of $951.7M, up 8% on both a reported and organic basis. GAAP diluted EPS was $1.95; adjusted diluted EPS reached a record $2.33, up 15% YoY. Orders surged 13% organically to $991M. The company raised full-year 2026 guidance for both organic sales growth (6.5%–6.8%, up from 5%–6%) and adjusted diluted EPS ($8.91–$8.96, up from $8.70–$8.85).
- Q3 orders hit $991M, up 13% organic YoY, nearly $1B in a single quarter.
- Adjusted diluted EPS of $2.33 beat prior-year $2.03 by 15%; GAAP diluted EPS was $1.95.
- Full-year adjusted EPS guidance raised to $8.91–$8.96 from $8.70–$8.85, ~12% YoY at midpoint.
- HST segment led with 13% organic sales growth driven by AI-related data center and semiconductor demand.
- Free cash flow of $214.3M for Q3, 124% conversion rate on adjusted net income.
Markets closed — no regular-session reaction yet; extended-hours move not captured here. Given the record sales, double-digit EPS growth, guidance raise, and $991M order book, the print is likely to be received positively when trading resumes.
IDEX posted a clean beat-and-raise quarter with record results, nearly $1B in orders, and raised guidance — signaling broad-based industrial momentum and AI-infrastructure tailwinds.
IDEX's HST segment is benefiting from the same AI infrastructure buildout tailwinds seen across industrial peers, with 13% organic growth in data center and semiconductor-exposed businesses. The broad-based order strength across all three segments suggests industrial demand is accelerating.
Forward-looking risks cited include inflation/price-cost headwinds, tariffs and trade policy changes, AI-driven demand volatility, and integration risks from acquisitions. Restructuring charges tied to an HST facility closure continue.